SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Tetratherix TTX.AX: FDA review update for Tegenix 510(k) submission

FDA confirms device classification, predicate device and performance data for Tegenix; requests extra detail on chemical characterisation and product labelling.

TTX.AX